Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Dec;38(6):692–698. doi: 10.1038/bjc.1978.274

Serological response to intracaecal injections of antigenic mouse tumour cells.

M L Laursen
PMCID: PMC2009818  PMID: 369587

Abstract

Immunofluorescence studies of sera from mice with induced enhancement of tumour growth demonstrated that these sera contained factors ("interfering factors") which in an apparently competitive manner interfered with the subsequent binding of specific antibodies to antigenic sites on the tumour-cell membrane. The factors were tumour-specific but lacked some of the immunoglobulin determinants. They could not be detected by polyvalent FITC-antimouse gamma-globulin. Interfering factors did not seem to be related to IgA or IgE. They were demonstrable in sera from tumour-free animals without growing tumours, thus differing from the tumour-specific "blocking factors".

Full text

PDF
692

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Embleton M. J., Robins R. A. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status. Int J Cancer. 1973 Jan 15;11(1):1–10. doi: 10.1002/ijc.2910110102. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  3. Baldwin R. W., Price M. R. Tumor antigens and tumor-host relationships. Annu Rev Med. 1976;27:151–163. doi: 10.1146/annurev.me.27.020176.001055. [DOI] [PubMed] [Google Scholar]
  4. Bazin H., Maldague P., Heremans J. F. The metabolism of different immunoglobulin classes in irradiated mice. II. Role of the gut. Immunology. 1970 Mar;18(3):361–368. [PMC free article] [PubMed] [Google Scholar]
  5. Crabbé P. A., Nash D. R., Bazin H., Eyssen D. V., Heremans J. F. Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin. J Exp Med. 1969 Oct 1;130(4):723–744. doi: 10.1084/jem.130.4.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Currie G. A., Basham C. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen. Br J Cancer. 1972 Dec;26(6):427–438. doi: 10.1038/bjc.1972.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dolezel J., Bienenstock J. A and non- A immune response after oral and parenteral immunization of the hamster. Cell Immunol. 1971 Oct;2(5):458–468. doi: 10.1016/0008-8749(71)90056-6. [DOI] [PubMed] [Google Scholar]
  8. Hellström K. E., Hellström I., Nepom J. T. Specific blocking factors--are they important? Biochim Biophys Acta. 1977 Dec 23;473(2):121–148. doi: 10.1016/0304-419x(77)90003-8. [DOI] [PubMed] [Google Scholar]
  9. KALISS N. Immunological enhancement of tumor homografts in mice: a review. Cancer Res. 1958 Oct;18(9):992–1003. [PubMed] [Google Scholar]
  10. KLEIN E., KLEIN G. ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT. J Natl Cancer Inst. 1964 Mar;32:547–568. [PubMed] [Google Scholar]
  11. Kaliss N. Dynamics of immunologic enhancement. Transplant Proc. 1970 Mar;2(1):59–67. [PubMed] [Google Scholar]
  12. Kieler J., Radzikowski C., Moore J., Ulrich K. Tumorigenicity and isoimmunizing properties of C3H mouse cells undergoing "spontaneous" malignant conversion in vitro. J Natl Cancer Inst. 1972 Feb;48(2):393–405. [PubMed] [Google Scholar]
  13. Laursen M. L., Laursen K. Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route. Br J Cancer. 1978 Jun;37(6):1039–1045. doi: 10.1038/bjc.1978.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Monti-Bragadin C., Ulrich K. Rescue of the genome of the defective murine sarcoma virus from a non-producer hamster tumor cell line, PM-1, with murine and feline leukemia viruses as helpers. Int J Cancer. 1972 Mar 15;9(2):383–392. doi: 10.1002/ijc.2910090217. [DOI] [PubMed] [Google Scholar]
  15. Mota I. Biological characterization of mouse 'early' antibodies. Immunology. 1967 Mar;12(3):343–348. [PMC free article] [PubMed] [Google Scholar]
  16. Ran M., Witz I. P. Tumor-associated immunoglobulins. Enhancement of syngeneic tumors by IgG2-containing tumor eluates. Int J Cancer. 1972 Jan 15;9(1):242–247. doi: 10.1002/ijc.2910090126. [DOI] [PubMed] [Google Scholar]
  17. Sjögren H. O., Hellström I., Bansal S. C., Hellström K. E. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372–1375. doi: 10.1073/pnas.68.6.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Snell G. D. Immunologic enhancement. Surg Gynecol Obstet. 1970 Jun;130(6):1109–1119. [PubMed] [Google Scholar]
  19. Takasugi M., Hildemann W. H. Lymphocyte-antibody interactions in immunological enhancement. Transplant Proc. 1969 Mar;1(1):530–534. [PubMed] [Google Scholar]
  20. Takasugi M., Klein E. The role of blocking antibodies in immunological enhancement. Immunology. 1971 Oct;21(4):675–684. [PMC free article] [PubMed] [Google Scholar]
  21. Thomson D. M., Steele K., Alexander P. The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata. Br J Cancer. 1973 Jan;27(1):27–34. doi: 10.1038/bjc.1973.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vaerman J. P., André C., Bazin H., Heremans J. F. Mesenteric lymph as a major source of serum IgA in guinea pigs and rats. Eur J Immunol. 1973 Sep;3(9):580–584. doi: 10.1002/eji.1830030911. [DOI] [PubMed] [Google Scholar]
  23. Winn H. J. Humoral antibody in allograft reactions. Transplant Proc. 1970 Mar;2(1):83–91. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES